Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type

  title={Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type},
  author={Myrle M. Stouten-Kemperman and Michiel B. de Ruiter and Vincent Koppelmans and Willem Boogerd and L. Reneman and Sanne B Schagen},
  journal={Brain Imaging and Behavior},
Adjuvant chemotherapy (CT) for breast cancer (BC) is associated with very late side-effects on brain function and structure. However, little is known about neurotoxicity of specific treatment regimens. To compare neurotoxicity profiles after different treatment strategies, we used neurocognitive testing and multimodality MRI in BC survivors randomized to high-dose (HI), conventional-dose (CON-) CT or radiotherapy (RT) only and a healthy control (HC) group. BC survivors who received CON-CT (n… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 12 extracted citations


Publications referenced by this paper.
Showing 1-10 of 44 references

Alterations in brain

L. M. Kamendulis, A. J. Saykin

treatment : a 3 - year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls

K. L. Pomykala, M. B. de Ruiter, S. Deprez, B. C. McDonald, D. H. S. Silverman
View 1 Excerpt

Chemotherapy-related cognitive dysfunction.

Current neurology and neuroscience reports • 2012
View 1 Excerpt

Late effects of high-dose

G. Douaud, S. B. Schagen

Similar Papers

Loading similar papers…